Show simple item record

dc.contributor.authorGamboa S.U.
dc.contributor.authorFischer M.C.
dc.contributor.authorMartínez J.R.
dc.contributor.authorVéliz L.
dc.contributor.authorOrellana P.
dc.contributor.authorSolar A.
dc.contributor.authorBohmwald K.
dc.contributor.authorKalergis A.
dc.contributor.authorRiedel C.
dc.contributor.authorCorvalán A.H.
dc.contributor.authorRoa J.C.
dc.contributor.authorFuentealba R.
dc.contributor.authorCáceres C.J.
dc.contributor.authorLópez-Lastra M.
dc.contributor.authorLeón A.
dc.contributor.authorDroppelmann N.
dc.contributor.authorGonzález H.E.
dc.date.accessioned2020-09-02T22:18:41Z
dc.date.available2020-09-02T22:18:41Z
dc.date.issued2018
dc.identifier10.18632/oncotarget.23502
dc.identifier.citation9, 2, 2445-2467
dc.identifier.issn19492553
dc.identifier.urihttps://hdl.handle.net/20.500.12728/4576
dc.descriptionPapillary thyroid cancer (PTC) is the most prevalent endocrine neoplasia. The increased incidence of PTC in patients with thyroiditis and the frequent immune infiltrate found in PTC suggest that inflammation might be a risk factor for PTC development. The CXCR3-ligand system is involved in thyroid inflammation and CXCR3 has been found upregulated in many tumors, suggesting its pro-tumorigenic role under the inflammatory microenvironment. CXCR3 ligands (CXCL4, CXCL9, CXCL10 and CXCL11) trigger antagonistic responses partly due to the presence of two splice variants, CXCR3A and CXCR3B. Whereas CXCR3A promotes cell proliferation, CXCR3B induces apoptosis. However, the relation between CXCR3 variant expression with chronic inflammation and PTC development remains unknown. Here, we characterized the expression pattern of CXCR3 variants and their ligands in benign tumors and PTC. We found that CXCR3A and CXCL10 mRNA levels were increased in non-metastatic PTC when compared to non-neoplastic tissue. This increment was also observed in a PTC epithelial cell line (TPC-1). Although elevated protein levels of both isoforms were detected in benign and malignant tumors, the CXCR3A expression remained greater than CXCR3B and promoted proliferation in Nthy-ori-3-1 cells. In non-metastatic PTC, inflammation was conditioning for the CXCR3 ligands increased availability. Consistently, CXCL10 was strongly induced by interferon gamma in normal and tumor thyrocytes. Our results suggest that persistent inflammation upregulates CXCL10 expression favoring tumor development via enhanced CXCR3A-CXCL10 signaling. These findings may help to further understand the contribution of inflammation as a risk factor in PTC development and set the basis for potential therapeutic studies.
dc.language.isoen
dc.publisherImpact Journals LLC
dc.subjectChemokine receptors
dc.subjectCXCL10
dc.subjectCXCR3
dc.subjectInflammation
dc.subjectPapillary thyroid cancer
dc.subjectchemokine receptor CXCR3
dc.subjectchemokine receptor CXCR3A
dc.subjectchemokine receptor CXCR3B
dc.subjectgamma interferon
dc.subjectgamma interferon inducible protein 10
dc.subjectmessenger RNA
dc.subjectunclassified drug
dc.subjectadult
dc.subjectArticle
dc.subjectcarcinogenesis
dc.subjectcell proliferation
dc.subjectclinical article
dc.subjectcontrolled study
dc.subjectfemale
dc.subjecthuman
dc.subjecthuman tissue
dc.subjectinflammation
dc.subjectlymph node metastasis
dc.subjectmale
dc.subjectNthy-ori 3-1 cell line
dc.subjectprotein expression
dc.subjectthyroid follicular cell
dc.subjectthyroid papillary carcinoma
dc.subjectthyroiditis
dc.subjectTPC-1 cell line
dc.titleDifferential expression profile of CXCR3 splicing variants is associated with thyroid neoplasia. Potential role in papillary thyroid carcinoma oncogenesis?
dc.typeArticle


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record